SYPL1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 9.89652804150865E-13 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
2.39809999635909E-08 |
Normal-vs-Stage2 |
1.007490E-04 |
Normal-vs-Stage3 |
1.4432899320127E-15 |
Normal-vs-Stage4 |
1.63935531816151E-12 |
Stage1-vs-Stage2 |
8.583600E-01 |
Stage1-vs-Stage3 |
8.31610000000538E-05 |
Stage1-vs-Stage4 |
7.396900E-04 |
Stage2-vs-Stage3 |
2.783700E-02 |
Stage2-vs-Stage4 |
3.661900E-02 |
Stage3-vs-Stage4 |
9.250000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
6.66244837077556E-13 |
Normal-vs-AfricanAmerican |
1.82840409479468E-11 |
Normal-vs-Asian |
2.862000E-02 |
Caucasian-vs-AfricanAmerican |
2.140800E-01 |
Caucasian-vs-Asian |
6.298600E-01 |
AfricanAmerican-vs-Asian |
2.769400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.77635683940025E-15 |
Normal-vs-Female |
2.80159995202922E-09 |
Male-vs-Female |
1.470980E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.09029999975741E-08 |
Normal-vs-Age(41-60Yrs) |
3.29599680881643E-11 |
Normal-vs-Age(61-80Yrs) |
1.68742797512778E-12 |
Normal-vs-Age(81-100Yrs) |
5.97399999999748E-05 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.555380E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.116000E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.226200E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.085200E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.497400E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.568000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
9.501700E-03 |
Normal-vs-Grade 2 |
4.28360000026551E-07 |
Normal-vs-Grade 3 |
1.62447832963153E-12 |
Normal-vs-Grade 4 |
1.62447832963153E-12 |
Grade 1-vs-Grade 2 |
9.752200E-01 |
Grade 1-vs-Grade 3 |
6.651500E-02 |
Grade 1-vs-Grade 4 |
6.008900E-04 |
Grade 2-vs-Grade 3 |
7.64040000000854E-05 |
Grade 2-vs-Grade 4 |
3.28399973881233E-10 |
Grade 3-vs-Grade 4 |
5.607200E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
2.45659999997816E-06 |
Normal-vs-ccB subtype |
1.63147273468667E-12 |
ccA subtype-vs-ccB subtype |
1.74940999999595E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
5.98250338157413E-11 |
Normal-vs-N1 |
3.32039999939582E-08 |
N0-vs-N1 |
4.050200E-02 |
|
|